These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24941874)

  • 1. The identification of high-affinity G protein-coupled receptor ligands from large combinatorial libraries using multicolor quantum dot-labeled cell-based screening.
    Fu J; Lee T; Qi X
    Future Med Chem; 2014 May; 6(7):809-23. PubMed ID: 24941874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology.
    Dohlman HG
    J Biol Chem; 2015 Aug; 290(32):19469-70. PubMed ID: 26126823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneous time-resolved G protein-coupled receptor-ligand binding assay based on fluorescence cross-correlation spectroscopy.
    Antoine T; Ott D; Ebell K; Hansen K; Henry L; Becker F; Hannus S
    Anal Biochem; 2016 Jun; 502():24-35. PubMed ID: 26954998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors.
    Morfa CJ; Bassoni D; Szabo A; McAnally D; Sharir H; Hood BL; Vasile S; Wehrman T; Lamerdin J; Smith LH
    Assay Drug Dev Technol; 2018 Oct; 16(7):384-396. PubMed ID: 30251873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.
    Gruber CW; Muttenthaler M; Freissmuth M
    Curr Pharm Des; 2010; 16(28):3071-88. PubMed ID: 20687879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of machine learning in GPCR bioactive ligand discovery.
    Jabeen A; Ranganathan S
    Curr Opin Struct Biol; 2019 Apr; 55():66-76. PubMed ID: 31005679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and screening of bead-displayed combinatorial libraries.
    Doran TM; Dickson P; Ndungu JM; Ge P; Suponitsky-Kroyter I; An H; Kodadek T
    Methods Enzymol; 2019; 622():91-127. PubMed ID: 31155067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs).
    Wang D; Li Y; Zhang Y; Liu Y; Shi G
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):232-41. PubMed ID: 22221056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass-spectrometry-based method for screening of new peptide ligands for G-protein-coupled receptors.
    Cologna CT; Gilles N; Echterbille J; Degueldre M; Servent D; de Pauw E; Quinton L
    Anal Bioanal Chem; 2015 Jul; 407(18):5299-307. PubMed ID: 25935673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual Screening of a Chemically Diverse "Superscaffold" Library Enables Ligand Discovery for a Key GPCR Target.
    Grotsch K; Sadybekov AV; Hiller S; Zaidi S; Eremin D; Le A; Liu Y; Smith EC; Illiopoulis-Tsoutsouvas C; Thomas J; Aggarwal S; Pickett JE; Reyes C; Picazo E; Roth BL; Makriyannis A; Katritch V; Fokin VV
    ACS Chem Biol; 2024 Apr; 19(4):866-874. PubMed ID: 38598723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.